In second exchange final rule . . .

CMS Lowers Cost-Sharing Max, Will Reissue Regs On 1332s

By Amy Lotven / April 30, 2021 at 6:47 PM
Editor's Note: This story was updated to clarify that CMS determined GA's 1332 Waiver followed statutory guardrails. CMS Friday (April 30) released the second half of the 2022 exchange regulation , which tweaks the proposed premium growth rate to lower annual cost-sharing by about $400. The agency also says it will issue a rule later this year that will increase the exchange user fee and alter some of the controversial provisions from the Trump administration’s January rule,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.